CG Oncology, Inc.
CG Oncology, Inc. (CGON) has a dated narrative snapshot, but its priced-in model claim is temporarily suppressed because the model-solve record is unavailable or has changed.
222 institutional managers reported holding CGON in 13F filings for the quarter ended 2026-03-31. 54 opened new positions that quarter. Held by Vanguard Group, Wellington Management, BlackRock, among others. On the short side, 10.6M shares were sold short as of the 2026-06-15 count, about 12% of shares outstanding (11.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
Open-market insider buys at CGON over the trailing three years: 2024: 4 buys totaling $12.66M. 5 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CGON's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2024-08-09 | +8.5% | +7.2% |
| 2024-11-13 | -11.5% | -15.8% |
| 2025-03-29 | -1.8% | -3.0% |
| 2025-05-14 | -3.8% | +8.0% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CGON's latest 8-K filings: 2026-06-08 (items 5.07); 2026-05-26 (items 5.02); 2026-05-08 (items 2.02, 9.01); 2026-04-13 (items 5.02, 9.01); 2026-02-27 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.